T
Tatsuo Kanda
Researcher at Nihon University
Publications - 384
Citations - 8091
Tatsuo Kanda is an academic researcher from Nihon University. The author has contributed to research in topics: Hepatitis C virus & Hepatocellular carcinoma. The author has an hindex of 39, co-authored 355 publications receiving 6848 citations. Previous affiliations of Tatsuo Kanda include Chiba University & Saint Louis University.
Papers
More filters
Journal ArticleDOI
Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease
Hajime Sumi,Osamu Yokosuka,Naohiko Seki,Makoto Arai,Fumio Imazeki,Tomoko Kurihara,Tatsuo Kanda,Kenichi Fukai,Masaki Kato,Hiromitsu Saisho +9 more
TL;DR: Although the patients with genotype B experience earlier HBe seroconversion, slower progression of liver fibrosis, and slower development of HCC, the life‐long risk of progression to advanced fibrosis and development ofHCC may not differ among genotypes B‐ and C‐related chronic liver disease.
Journal ArticleDOI
Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors
Takeshi Niinuma,Hiromu Suzuki,Masanori Nojima,Katsuhiko Nosho,Hiroyuki Yamamoto,Hiroyuki Takamaru,Eiichiro Yamamoto,Reo Maruyama,Takayuki Nobuoka,Yasuaki Miyazaki,Toshirou Nishida,Takeo Bamba,Tatsuo Kanda,Yoichi Ajioka,Takahiro Taguchi,Satoshi Okahara,Hiroaki Takahashi,Yasunori Nishida,Masao Hosokawa,Tadashi Hasegawa,Takashi Tokino,Koichi Hirata,Kohzoh Imai,Minoru Toyota,Yasuhisa Shinomura +24 more
TL;DR: Findings reveal concurrent overexpression of HOX genes with noncoding RNAs in human cancer in this setting, revealing miR-196a and HOTAIR as potentially useful biomarkers and therapeutic targets in malignant GISTs.
Journal ArticleDOI
Hepatitis C Virus Genotype 1a Growth and Induction of Autophagy
TL;DR: It is suggested that HCV genotype 1a (clone H77) can be serially passaged in IHH and thatHCV infection induces an autophagic response in hepatocytes.
Journal ArticleDOI
APASL consensus statements and recommendation on treatment of hepatitis C
Masao Omata,Tatsuo Kanda,Lai Wei,Ming-Lung Yu,Wang-Long Chuang,Alaaeldin Ibrahim,Cosmas Rinaldi Adithya Lesmana,Jose D. Sollano,Manoj Kumar,Ankur Jindal,Barjesh Chander Sharma,Saeed Hamid,A. Kadir Dokmeci,Mamun-Al-Mahtab,G.W. McCaughan,Jafri Wasim,Darrell H. G. Crawford,Jia-Horng Kao,Osamu Yokosuka,George K. K. Lau,Shiv Kumar Sarin +20 more
TL;DR: Recommendations on treatment of hepatitis C are presented in this review after an international working party gathered at Istanbul Congress Center, Istanbul, Turkey on 13 March 2015.
Journal ArticleDOI
Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review
TL;DR: The literature suggests that genetic and epigenetic factors play a role in liver cirrhosis and its progression to HCC, and that HBV- and HCV-encoded proteins appear to be involved in hepatocarcinogenesis.